(Total Views: 693)
Posted On: 07/13/2020 6:10:08 AM
Post# of 153903
Update on HIV-BLA-PDUFA: FDA requested more information to complete a substantive review. No additional trials required. CytoDyn plans to submit the requested information and will ask for a Type A meeting with the FDA per the agency’s suggestion
(0)
(0)
